Keratinocyte proliferation machinery

The keratinocyte proliferation machinery refers to the integrated network of signaling pathways, cell cycle regulators, and growth factors that govern the division and renewal of keratinocytes in the epidermis. Key components of this system include the Epidermal Growth Factor Receptor (EGFR), the Mitogen-Activated Protein Kinase (MAPK) pathway, and the Janus Kinase/Signal Transducer and Activator of Transcription (JAK/STAT) cascade, which collectively drive the transition of cells through the mitotic cycle (StatPearls, 2023; PubMed, PMC7350189). In healthy skin, this machinery is tightly regulated to maintain epidermal thickness and barrier function while allowing for rapid re-epithelialization following injury (NIH, 2022). Pathological overactivation of these pathways is a hallmark of hyperproliferative skin diseases such as psoriasis, where inflammatory cytokines like IL-17 and IL-22 force the machinery into a state of rapid, uncontrolled turnover. Therapeutic interventions often target specific nodes within this machinery, such as using antimetabolites like methotrexate to inhibit DNA synthesis or biologics to block the upstream signals that trigger the proliferative response (DrugBank, 2024).

Other names

Epidermal proliferation machineryKeratinocyte cell cycle apparatusEpidermal growth signaling network

Inhibition of DNA synthesis, modulation of growth factor signaling (e.g., EGFR, JAK/STAT), and regulation of cell cycle checkpoints to reduce excessive mitotic activity.